RxDoctor Payments Data

Philip Lynn, MD

Internal Medicine · Garden Grove, CANPI 1326044819

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 20th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Medicare billing

Part B allowed, 2024
$455,408
Medicare patients
166
Services billed
6,115

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin59$78,063
TradjentaLinagliptin35$35,107
JanuviaSitagliptin Phosphate21$29,075
RestasisCyclosporine28$22,223
XareltoRivaroxaban17$16,870
LinzessLinaclotide16$15,229
ArexvyRsvpref3 Antigen/As01e/Pf52$14,793
VascepaIcosapent Ethyl37$13,524
Cyclosporine19$12,442
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$11,712
GemtesaVibegron17$11,596
ShingrixVaricella-Zoster Ge/As01b/Pf20$3,939
Atorvastatin Calcium308$3,084
Rosuvastatin Calcium132$2,575
Betamethasone Dipropionate36$2,461

Paid to pharmacies, not to this prescriber.

Other internal medicine in Garden Grove

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →